Teachers Advisors’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRO
AVAI
AI
BI
RCM
RSCM
VMI
AG
AIC
Teachers Advisors's SPRO Position: Q1 2018 in Review
Teachers Advisors sold out of Spero Therapeutics (SPRO) in Q1 2018, closing a stake of 6,931 shares — an estimated $81K sold.
Teachers Advisors first reported a position in SPRO in Q4 2017 and held it in 1 quarter. The position peaked at $81K in Q4 2017. 35 funds tracked by Wall St. Rank hold SPRO as of Q1 2018.
- Teachers Advisors reported no remaining Spero Therapeutics position as of Q1 2018 after selling out during the quarter.
- Teachers Advisors sold 6,931 Spero Therapeutics shares in Q1 2018, an estimated $81K.
- Teachers Advisors first reported a position in Spero Therapeutics in Q4 2017 and held it in 1 quarter.
- Teachers Advisors's Spero Therapeutics position peaked at $81K in Q4 2017.
- 35 funds tracked by Wall St. Rank held Spero Therapeutics as of Q1 2018.
Based on Teachers Advisors's 13F filing for Q1 2018, filed 14 May 2018.